BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 25015037)

  • 1. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030.
    Antonelli JA; Maalouf NM; Pearle MS; Lotan Y
    Eur Urol; 2014 Oct; 66(4):724-9. PubMed ID: 25015037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of kidney stones in the United States.
    Scales CD; Smith AC; Hanley JM; Saigal CS;
    Eur Urol; 2012 Jul; 62(1):160-5. PubMed ID: 22498635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Trends in Kidney Stone Among Adults in the USA: Analyses of National Health and Nutrition Examination Survey 2007-2018 Data.
    Abufaraj M; Xu T; Cao C; Waldhoer T; Seitz C; D'andrea D; Siyam A; Tarawneh R; Fajkovic H; Schernhammer E; Yang L; Shariat SF
    Eur Urol Focus; 2021 Nov; 7(6):1468-1475. PubMed ID: 32900675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and urolithiasis: evidence of regional influences.
    Trinchieri A; Croppi E; Montanari E
    Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Jodi A. Antonelli, Naim M. Maalouf, Margaret S. Pearle, Yair Lotan. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol 2014;66:724-9.
    Arrabal-Polo MA; Cano-García Mdel C; Arrabal-Martin M
    Eur Urol; 2015 May; 67(5):e96. PubMed ID: 25530611
    [No Abstract]   [Full Text] [Related]  

  • 6. Association Between Body Fat Mass and Kidney Stones in US Adults: Analysis of the National Health and Nutrition Examination Survey 2011-2018.
    Abufaraj M; Siyam A; Xu T; Imm K; Cao C; Waldoer T; Schernhammer E; Shariat SF; Yang L
    Eur Urol Focus; 2022 Mar; 8(2):580-587. PubMed ID: 33737023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study.
    Daels FP; Gaizauskas A; Rioja J; Varshney AK; Erkan E; Ozgok Y; Melekos M; de la Rosette JJ
    World J Urol; 2015 Jun; 33(6):859-64. PubMed ID: 25155035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Kidney Stones in the United States: The Continuous National Health and Nutrition Examination Survey.
    Hill AJ; Basourakos SP; Lewicki P; Wu X; Arenas-Gallo C; Chuang D; Bodner D; Jaeger I; Nevo A; Zell M; Markt SC; Eisner BH; Shoag JE
    J Urol; 2022 Apr; 207(4):851-856. PubMed ID: 34854755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity prevalence in Mexico: impact on health and economic burden.
    Rtveladze K; Marsh T; Barquera S; Sanchez Romero LM; Levy D; Melendez G; Webber L; Kilpi F; McPherson K; Brown M
    Public Health Nutr; 2014 Jan; 17(1):233-9. PubMed ID: 23369462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic severity and risk of kidney stone disease.
    Weinberg AE; Patel CJ; Chertow GM; Leppert JT
    Eur Urol; 2014 Jan; 65(1):242-7. PubMed ID: 23523538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994.
    West B; Luke A; Durazo-Arvizu RA; Cao G; Shoham D; Kramer H
    Am J Kidney Dis; 2008 May; 51(5):741-7. PubMed ID: 18436084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of stone surgery.
    Turney BW; Reynard JM
    Eur Urol; 2014 Oct; 66(4):730-1. PubMed ID: 25047175
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system.
    Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
    BJU Int; 2012 Dec; 110(11 Pt C):E1060-7. PubMed ID: 22686216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projecting the future diabetes population size and related costs for the U.S.
    Huang ES; Basu A; O'Grady M; Capretta JC
    Diabetes Care; 2009 Dec; 32(12):2225-9. PubMed ID: 19940225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness.
    Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
    J Urol; 2013 Mar; 189(3):935-9. PubMed ID: 23017509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency department visits in the United States for upper urinary tract stones: trends in hospitalization and charges.
    Ghani KR; Roghmann F; Sammon JD; Trudeau V; Sukumar S; Rahbar H; Kumar R; Karakiewicz PI; Peabody JO; Menon M; Sun M; Trinh QD
    J Urol; 2014 Jan; 191(1):90-6. PubMed ID: 23933053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender Equivalence in the Prevalence of Nephrolithiasis among Adults Younger than 50 Years in the United States.
    Tundo G; Khaleel S; Pais VM
    J Urol; 2018 Dec; 200(6):1273-1277. PubMed ID: 30059688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological trends in urolithiasis: impact on our health care systems.
    Trinchieri A
    Urol Res; 2006 Apr; 34(2):151-6. PubMed ID: 16440192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of Urolithiasis: Trends in Prevalence, Treatments, and Costs.
    Raheem OA; Khandwala YS; Sur RL; Ghani KR; Denstedt JD
    Eur Urol Focus; 2017 Feb; 3(1):18-26. PubMed ID: 28720363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and kidney stone disease: a systematic review.
    Carbone A; Al Salhi Y; Tasca A; Palleschi G; Fuschi A; De Nunzio C; Bozzini G; Mazzaferro S; Pastore AL
    Minerva Urol Nefrol; 2018 Aug; 70(4):393-400. PubMed ID: 29856171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.